Cancer, data and the fallacy of the $1000 genome

d

Here’s Mark’s key message:  The time of the $1000 genome meme is over.  It served us well for years –  driving advances in instrumentation, chemistry and biology.  But now it is reducing clinical credibility.  It’s time for it to leave the lexicon of healthcare; it has to go.

View the original article here: Cancer, Data and the Fallacy of the $1000 Genome – Forbes

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}
skin microbiome x final

Infographic: Could gut bacteria help us diagnose and treat diseases? This is on the horizon thanks to CRISPR gene editing

Humans are never alone. Even in a room devoid of other people, they are always in the company of billions ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.